Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Renal Cell Carcinoma Mouse Monoclonal Antibody

<strong>Renal Cell Carcinoma Mouse Monoclonal Antibody</strong> <strong>Catalog number:</strong> B2019878 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 ML <strong>Molecular Weight or Concentration:</strong> NA <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Motzer, R. J., et al. (2013). "Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase 3 Trial." Journal of Clinical Oncology. 2. Rini, B. I., et al. (2007). "Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma." New England Journal of Medicine. 3. Escudier, B., et al. (2016). "CheckMate 025: Nivolumab versus Everolimus in Advanced Renal Cell Carcinoma." The Lancet. 4. Heng, D. Y., et al. (2009). "External Validation of the International Metastatic Renal Cell Carcinoma Database Consortium Model for Survival Prediction: A Multi-Institutional Study." Journal of Clinical Oncology. 5. Choueiri, T. K., et al. (2015). "Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma." New England Journal of Medicine. 6. Karam, J. A., et al. (2016). "The Role of Surgery in the Management of Metastatic Renal Cell Carcinoma." Urologic Clinics of North America. 7. Albiges, L., et al. (2016). "A Global Perspective on the Management of Renal Cell Carcinoma: A Review of the Current Guidelines and Future Directions." European Urology. 8. Motzer, R. J., et al. (2015). "A Phase 3 Trial of Atezolizumab in Patients with Metastatic Renal Cell Carcinoma." The Lancet Oncology. 9. Kauffman, E. C., et al. (2014). "Renal Cell Carcinoma: A Review of the Current Literature and Future Directions." Cancer Treatment Reviews. 10. Znaor, A., et al. (2015). "Trends in Renal Cell Carcinoma Incidence and Mortality in Europe: A Review of the Literature." European Journal of Cancer. <a href="Renal Cell Carcinoma Mouse Monoclonal Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=Renal Cell Carcinoma</a> <br><strong>Products Related to Renal Cell Carcinoma Mouse Monoclonal Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>

Product Specifications

CAS Number

9007-83-4

Short Description

Catalog Number: B2019878 (1 ML)

Weight

0.3

Length

2

Width

0.5

Height

0.5

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

HLA-Aw32 & HLA-A25 (MHC I) (CATA-1), CF488A conjugate, 0.1mg/mL
BNC881073-500 1x 500 µL

HLA-Aw32 & HLA-A25 (MHC I) (CATA-1), CF488A conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Eosinophil Peroxidase (AHE-1), CF488A conjugate, 0.1mg/mL
BNC881231-500 1x 500 µL

Eosinophil Peroxidase (AHE-1), CF488A conjugate, 0.1mg/mL

Sign In for Pricing
View Details
MUC18 / Mucin 18 / CD146 (OJ79c), CF594 conjugate, 0.1mg/mL
BNC940676-500 1x 500 µL

MUC18 / Mucin 18 / CD146 (OJ79c), CF594 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
HSP60 (LK1), CF594 conjugate, 0.1mg/mL
BNC940851-500 1x 500 µL

HSP60 (LK1), CF594 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD56 / NCAM1 / NKH1 (Neuronal Cell Marker) (NCAM1/2217R), CF640R conjugate, 0.1mg/mL
BNC402217-100 1x 100 µL

CD56 / NCAM1 / NKH1 (Neuronal Cell Marker) (NCAM1/2217R), CF640R conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Cdk2 / p34cdc2 Serine-Threonine Kinase (AN4.3), CF405S conjugate, 0.1mg/mL
BNC042316-100 1x 100 µL

Cdk2 / p34cdc2 Serine-Threonine Kinase (AN4.3), CF405S conjugate, 0.1mg/mL

Sign In for Pricing
View Details